BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 9400593)

  • 21. The block in assembly of modified vaccinia virus Ankara in HeLa cells reveals new insights into vaccinia virus morphogenesis.
    Sancho MC; Schleich S; Griffiths G; Krijnse-Locker J
    J Virol; 2002 Aug; 76(16):8318-34. PubMed ID: 12134037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The combination of marker gene swapping and fluorescence-activated cell sorting improves the efficiency of recombinant modified vaccinia virus Ankara vaccine production for human use.
    Di Lullo G; Soprana E; Panigada M; Palini A; Agresti A; Comunian C; Milani A; Capua I; Erfle V; Siccardi AG
    J Virol Methods; 2010 Feb; 163(2):195-204. PubMed ID: 19778556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enveloped virus is the major virus form produced during productive infection with the modified vaccinia virus Ankara strain.
    Spehner D; Drillien R; Proamer F; Houssais-Pêcheur C; Zanta MA; Geist M; Dott K; Balloul JM
    Virology; 2000 Jul; 273(1):9-15. PubMed ID: 10891402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine.
    Blanchard TJ; Alcami A; Andrea P; Smith GL
    J Gen Virol; 1998 May; 79 ( Pt 5)():1159-67. PubMed ID: 9603331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence.
    Meyer H; Sutter G; Mayr A
    J Gen Virol; 1991 May; 72 ( Pt 5)():1031-8. PubMed ID: 2033387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Design and construction of transfer vectors in order to obtain recombinant modified vaccinia virus Ankara (MVA)].
    Ferrer MF; Zanetti FA; Calamante G
    Rev Argent Microbiol; 2007; 39(3):138-42. PubMed ID: 17987847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spontaneous and Targeted Mutations in the Decapping Enzyme Enhance Replication of Modified Vaccinia Virus Ankara (MVA) in Monkey Cells.
    Erez N; Wyatt LS; Americo JL; Xiao W; Moss B
    J Virol; 2021 Sep; 95(19):e0110421. PubMed ID: 34232734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Easy and efficient protocols for working with recombinant vaccinia virus MVA.
    Kremer M; Volz A; Kreijtz JH; Fux R; Lehmann MH; Sutter G
    Methods Mol Biol; 2012; 890():59-92. PubMed ID: 22688761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modified vaccinia virus Ankara protein F1L is a novel BH3-domain-binding protein and acts together with the early viral protein E3L to block virus-associated apoptosis.
    Fischer SF; Ludwig H; Holzapfel J; Kvansakul M; Chen L; Huang DC; Sutter G; Knese M; Häcker G
    Cell Death Differ; 2006 Jan; 13(1):109-18. PubMed ID: 16003387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repair of a previously uncharacterized second host-range gene contributes to full replication of modified vaccinia virus Ankara (MVA) in human cells.
    Peng C; Moss B
    Proc Natl Acad Sci U S A; 2020 Feb; 117(7):3759-3767. PubMed ID: 32019881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitation of simian virus 40 T-antigen correlated with the cell cycle of permissive and non-permissive cells.
    Lehman JM; Friedrich TD; Laffin J
    Cytometry; 1993; 14(4):401-10. PubMed ID: 8390342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Herpes simplex virus type 1 strain HSV1716 grown in baby hamster kidney cells has altered tropism for nonpermissive Chinese hamster ovary cells compared to HSV1716 grown in vero cells.
    Conner J; Rixon FJ; Brown SM
    J Virol; 2005 Aug; 79(15):9970-81. PubMed ID: 16014957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of avian and mammalian cell cultures for the propagation of avian reovirus WVU 2937.
    Barta V; Springer WT; Millar DL
    Avian Dis; 1984; 28(1):216-23. PubMed ID: 6721794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of replication-deficient vaccinia virus/T7 RNA polymerase hybrid expression: effect of T7 RNA polymerase levels and alpha-amanitin.
    Engleka KA; Lewis EW; Howard BH
    Virology; 1998 Apr; 243(2):331-9. PubMed ID: 9568032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the replication characteristics of vaccinia virus strains Guang 9 and Tian Tan in vivo and in vitro.
    Zhu R; Liu Q; Huang W; Yu Y; Wang Y
    Arch Virol; 2014 Oct; 159(10):2587-96. PubMed ID: 24838849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Construction and biological characteristic for the recombinant modified vaccinia virus ankara co-expressing modified GP5 and M protein of porcine reproductive and respiratory syndrome virus].
    Zheng Q; Li P; Cao R; Hou J; Chen P
    Sheng Wu Gong Cheng Xue Bao; 2008 May; 24(5):766-73. PubMed ID: 18724695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modified vaccinia virus Ankara for delivery of human tyrosinase as melanoma-associated antigen: induction of tyrosinase- and melanoma-specific human leukocyte antigen A*0201-restricted cytotoxic T cells in vitro and in vivo.
    Drexler I; Antunes E; Schmitz M; Wölfel T; Huber C; Erfle V; Rieber P; Theobald M; Sutter G
    Cancer Res; 1999 Oct; 59(19):4955-63. PubMed ID: 10519409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fowlpox virus host range restriction: gene expression, DNA replication, and morphogenesis in nonpermissive mammalian cells.
    Somogyi P; Frazier J; Skinner MA
    Virology; 1993 Nov; 197(1):439-44. PubMed ID: 8212580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vectors for recombinational cloning and gene expression in mammalian cells using modified vaccinia virus Ankara.
    Pradeau-Aubreton K; Ruff M; Garnier JM; Schultz P; Drillien R
    Anal Biochem; 2010 Sep; 404(1):103-5. PubMed ID: 20450873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct comparison of antigen production and induction of apoptosis by canarypox virus- and modified vaccinia virus ankara-human immunodeficiency virus vaccine vectors.
    Zhang X; Cassis-Ghavami F; Eller M; Currier J; Slike BM; Chen X; Tartaglia J; Marovich M; Spearman P
    J Virol; 2007 Jul; 81(13):7022-33. PubMed ID: 17409140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.